Many academic groups and university medical centres identify new uses for existing medicines, but few of these discoveries reach patients. This session will help knowledge transfer professionals recognise promising opportunities and understand how a company can take them forward.
Using real cases, including Guanabenz (Amsterdam UMC, GuanaRep), we will cover:
The session will end with a Q&A.
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
Join our newsletter and get the latest news